Type 1 Diabetes: Clinical Trials

11 trials for Type 1 Diabetes, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 terminated. 11 Phase 1, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 111Terminated 11
Phase 24Terminated 4

Follow Type 1 Diabetes: new trials by email Literature Review of Type 1 Diabetes trials Research Report on Type 1 Diabetes

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Premixed Glucagon/Insulin Solution for Faster Insulin Absorption in Type 1 Diabetes
Lyumjev 100 UNT/ML Injectable Solution, Premixed Lyumjev - Type 1 Diabetes
Phase 1 / Phase 2TerminatedSt. Olavs Hospital92025-04-012026-10-19
Study to Explore the Effect of Dapagliflozin and Stress in Adolescent and Adult Subjects With Type 1 Diabetes (T1D)
Dapagliflozin, Placebo oral tablet, Stress - Type 1 Diabetes, Diabetic Ketoacidosis
Phase 1TerminatedKinderkrankenhaus auf der Bult22022-05-182024-12-09
Effect of ZT-01 on Glucagon During Hypoglycemia in Type 1 Diabetes Mellitus
ZT-01 low dose, ZT-01 high dose, Placebo - Type 1 Diabetes, Hypoglycemia
Phase 1TerminatedZucara Therapeutics Inc.242021-07-082023-07-12
Glucagon Response to Prandial Insulin Administration in Persons With Type 1 Diabetes
Insulin - Type 1 Diabetes, Hyperglycemia, Postprandial
Phase 1 / Phase 2TerminatedWashington University School of Medicine12020-02-132022-10-07
Insulin Tolerance Test Study in Patients With Type 1 Diabetes
Pitolisant - Type 1 Diabetes, Hypoglycemia
Phase 1TerminatedHigh Point Clinical Trials Center52019-09-152021-04-02
A Study to Evaluate Safety, Engraftment, and Efficacy of VC-01 in Subjects With T1 Diabetes Mellitus
VC-01 Combination Product - Type 1 Diabetes
Phase 1 / Phase 2TerminatedViaCyte312019-06-252023-10-18
Intra-nasal Naloxone for Treatment of Impaired Awareness of Hypoglycemia
intra-nasal naloxone, Intra-nasal saline - Hypoglycemia Unawareness, Type 1 Diabetes
Phase 1 / Phase 2TerminatedUniversity of Minnesota112016-06-012023-03-27
Non Invasive Breath Based Acetone-meter- Easy Check
Easy Check - Type 1 Diabetes
Phase 1TerminatedRabin Medical Center62012-03-012018-05-15
Effects of Metreleptin in Type 1 Diabetes Mellitus
Leptin - Type 1 Diabetes
Phase 1TerminatedUniversity of Texas Southwestern Medical Center82010-09-012019-08-28
A Trial of 18F-AV-133 Positron Emission Tomography (PET)
18F-AV-133 - Type 1 Diabetes, Type 2 Diabetes
Phase 1TerminatedAvid Radiopharmaceuticals192010-06-012020-01-13
DIATOR-Diabetes Intervention With Atorvastatin
Atorvastatin, atorvastatin matching placebo - Type 1 Diabetes
Phase 1TerminatedProfil Institut für Stoffwechselforschung GmbH632004-03-012017-06-19

Narrower conditions

Diabetes Mellitus, Type 1 (11)  ·  Hypoglycemia (3)  ·  Diabetes Mellitus, Type 2 (1)  ·  Diabetic Ketoacidosis (1)  ·  Hyperglycemia (1)

Broader conditions

Autoimmune Diseases (11)  ·  Diabetes Mellitus (11)  ·  Endocrine System Diseases (11)  ·  Glucose Metabolism Disorders (11)  ·  Immune System Diseases (11)  ·  Metabolic Diseases (11)  ·  Nutritional and Metabolic Diseases (11)  ·  Acid-Base Imbalance (1)  ·  Acidosis (1)  ·  Diabetes Complications (1)  ·  Ketosis (1)

Interventions

Atorvastatin (1)  ·  Insulin (1)  ·  Leptin (1)  ·  Naloxone (1)  ·  adrenocorticotropin zinc (1)  ·  dapagliflozin (1)  ·  florbenazine F 18 (1)  ·  metreleptin (1)  ·  pitolisant (1)

Sponsors

Avid Radiopharmaceuticals (1)  ·  High Point Clinical Trials Center (1)  ·  Kinderkrankenhaus auf der Bult (1)  ·  Profil Institut für Stoffwechselforschung GmbH (1)  ·  Rabin Medical Center (1)  ·  St. Olavs Hospital (1)  ·  University of Minnesota (1)  ·  University of Texas Southwestern Medical Center (1)  ·  ViaCyte (1)  ·  Washington University School of Medicine (1)  ·  Zucara Therapeutics Inc. (1)

Countries

United States (6)  ·  Germany (2)  ·  Canada (1)  ·  Israel (1)  ·  Norway (1)

Top investigators

Abhimanyu Garg, M.D. (1)  ·  Amir Moheet, MD (1)  ·  Janet McGill, MD (1)  ·  Manasi Jaiman, MD (1)  ·  Melanie Fein, MD (1)  ·  Moshe Phillip, Prof (1)  ·  Richard Liggins, PhD (1)  ·  Stefan Martin, MD (1)  ·  Sven M Carlsen, MD PhD (1)  ·  Torben Biester, MD (1)

Results publications

PMID 21412424, PMID 22448235, PMID 23991111, PMID 42168649

NIH funding

2023 (1)